Skip to content

Arcutis Biotherapeutics, Inc.

ARQT Nasdaq SEC CIK 1787306

Follow Arcutis Biotherapeutics Weekly email: filings, results, news

News

3 stories filed under Arcutis Biotherapeutics, grouped into ongoing threads

Call

Thread · 2 stories

Arcutis Biotherapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation

Earnings 49 d ago

Arcutis Biotherapeutics, Inc. (ARQT) Q2 2026 Earnings Call Transcript

Earnings 49 d ago 2 sources

More coverage

Arcutis CEO Todd Watanabe sells $114,261 of ARQT stock

Markets 49 d ago

Profile

Headquarters: WESTLAKE VILLAGE, CA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

News · 3 stories clustered from the RSS aggregator